DE-labelling beta-lactam allergy using telemedicine and single dose oral challenge in a low risk paediatric cohort: Outcome of DE-labelling process one year later

  • Andrew Murphy

Research output: Other contribution (Published)Other contribution

Original languageEnglish (Ireland)
Media of outputOther Item
Volume75
Publication statusPublished - 1 Aug 2020

Cite this